Featured News
More News
Researchers including Dr. Michael Snyder and Dr. Philip Tsao identify more than 1,000 genes linked to severe COVID-19
Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.
Dr. Ananta Addala has won the Young Investigator Award for 2022
Dr. Ananta Addala has won the Young Investigator Award for 2022. This prize is supported by Medtronic.
Stanford Diabetes Research Center Member, Dr. Carolyn Bertozzi wins Nobel in chemistry
Stanford chemist Carolyn Bertozzi was awarded the Nobel Prize in chemistry for her development of bioorthogonal reactions, which allow scientists to explore cells and track biological processes without disrupting the normal chemistry of the cell.
Stanford Medicine, Dr. Tracey McLaughlin study: SARS-CoV-2 infects fat tissue, creates inflammatory storm cloud
Stanford Medicine scientists’ findings could explain why obese people have a higher risk of SARS-CoV-2 infection and are more likely to progress to severe disease and die of infection.
Dr. Danny Chou is recognized with the 2022 APS Early Career Lectureship
Danny Chou is an Assistant Professor of Pediatrics (Endocrinology and Diabetes) at Stanford University. He received his Ph.D. from Harvard University, working in the lab of Prof. Stuart Schreiber in 2011. His Ph.D. research involved the identification of suppressors of cytokine-induced apoptosis in pancreatic beta cells. He then moved to MIT, where he was a JDRF Postdoctoral Fellow in the Department of Chemical Engineering. He worked under the guidance of Profs. Robert Langer and Daniel Anderson, focusing on the development of glucose-responsive insulin derivatives.
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.